ILUMYA (tildrakizumab-asmn)

**Product type:** Human Prescription Drug

**Active ingredient:** TILDRAKIZUMAB

**Strength:** 100 mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Sun Pharmaceutical Industries, Inc.

**Marketing category:** BLA (BLA761067)

**Pharmacologic class:** Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]